SUBSCRIBE
SUBSCRIBE
News   Business

Acrux DDS Terminates Napa Biosciences License

November 8, 2005 | 
1 min read

08/11/2005 11:29:49 Acrux DDS, a wholly owned subsidiary of Melbourne-based Acrux (ASX:ACR), has terminated an exclusive license agreement it signed in May 2005 with US firm Napa Biosciences. More...

Alliances Australia
MORE ON THIS TOPIC
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
 · 
1 min read
 · 
Annalee Armstrong
Contemporary art collage of hand holding a dart aiming at the target. Business targeting, aiming, focus concept. Modern design. Copy space.
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
March 4, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
CRISPR, Cytiva Laying Off Employees
March 3, 2025
 · 
139 min read
 · 
BioSpace Editorial Staff
AbbVie's office in South San Francisco, California
Obesity
Obesity Late-Comer AbbVie Inks Up to $2.2B Amylin Deal With Gubra
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac